Skip to main content
. 2017 May 10;69(6):1207–1216. doi: 10.1161/HYPERTENSIONAHA.117.09156

Figure 3.

Figure 3.

NPNT (nephronectin) drives aldosterone production, likely through receptor ITGB1. A, NPNT overexpression increases protein-normalized aldosterone production, compared with vector control (n=4). B, NPNT silencing decreases protein-normalized aldosterone production, compared with nontargeting control (n=4). C, ITGB1 silencing decreases protein-normalized aldosterone production, compared with nontargeting control (n=4). Bars represent mean expression per group±SEM. Statistical analyses were conducted by Student t test. *P<0.05; **P<0.005; ***P<0.0005.